The complex relation between myocardial viability and functional recovery in chronic left ventricular dysfunction

L Agati1, C Autore, C Iacoboni

  • 1Department of Cardiovascular and Respiratory Sciences, La Sapienza University, Rome, Italy.

Insights

Identifying myocardial viability is crucial for patients with postischemic left ventricular dysfunction. Detecting hibernating myocardium helps predict outcomes and guide treatment decisions for improved prognosis.

Area of Science:

  • Cardiology
  • Nuclear Cardiology
  • Echocardiography

Background:

  • Postischemic left ventricular dysfunction necessitates evaluating myocardial viability for coronary revascularization.
  • Functional recovery after revascularization is not guaranteed solely by the presence of viable myocardium.
  • The interplay between myocardial necrosis and perfusion significantly influences outcomes.

Purpose of the Study:

  • To explore the role of myocardial viability in postischemic left ventricular dysfunction.
  • To compare diagnostic methods for detecting hibernating myocardium.
  • To assess the predictive value of different imaging techniques for functional recovery and prognosis.

Main Methods:

  • Review of current literature on myocardial viability assessment.
  • Comparison of thallium-201 scintigraphy, dobutamine echocardiography, and myocardial contrast echocardiography.
  • Analysis of the relationship between tissue viability, necrosis, perfusion, and left ventricular remodeling.

Main Results:

  • Thallium-201 scintigraphy shows high sensitivity for tissue viability.
  • Dobutamine echocardiography demonstrates high specificity for predicting functional recovery.
  • Myocardial contrast echocardiography uniquely assesses microvascular integrity, essential for viability and recovery.

Conclusions:

  • Combined use of scintigraphy, dobutamine echocardiography, and contrast echocardiography offers comprehensive assessment.
  • Myocardial viability, even without immediate functional recovery, can improve long-term prognosis by mitigating left ventricular remodeling.
  • Accurate assessment of myocardial viability is key to optimizing patient selection for coronary revascularization and predicting outcomes.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...